Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 19665066)

  • 1. A MLH1 polymorphism that increases cancer risk is associated with better outcome in sporadic colorectal cancer.
    Nejda N; Iglesias D; Moreno Azcoita M; Medina Arana V; González-Aguilera JJ; Fernández-Peralta AM
    Cancer Genet Cytogenet; 2009 Sep; 193(2):71-7. PubMed ID: 19665066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MLH1 region polymorphisms show a significant association with CpG island shore methylation in a large cohort of healthy individuals.
    Savio AJ; Lemire M; Mrkonjic M; Gallinger S; Zanke BW; Hudson TJ; Bapat B
    PLoS One; 2012; 7(12):e51531. PubMed ID: 23240038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian cancer risk is associated with a common variant in the promoter sequence of the mismatch repair gene MLH1.
    Harley I; Rosen B; Risch HA; Siminovitch K; Beiner ME; McLaughlin J; Sun P; Narod SA
    Gynecol Oncol; 2008 Jun; 109(3):384-7. PubMed ID: 18405947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of MLH1 single nucleotide polymorphisms with clinical outcomes of first-line irinotecan-based chemotherapy in colorectal cancer.
    Wang D; Zhang X; Zhang Y; Wu Y; Guan X; Zhu W; Wang M; Qi C; Shen B
    Onco Targets Ther; 2018; 11():8083-8088. PubMed ID: 30519050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation rs9929218 and risk of the colorectal Cancer and adenomas: A meta-analysis.
    Wang H; Gu D; Yu M; Hu Y; Chen Z; Huo X; Yu T; Chen J; Zheng Y
    BMC Cancer; 2021 Feb; 21(1):190. PubMed ID: 33627078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NME1 and DCC variants are associated with susceptibility and tumor characteristics in Mexican patients with colorectal cancer.
    Márquez-González RM; Saucedo-Sariñana AM; de Jesús Tovar-Jacome C; Barros-Núñez P; Gallegos-Arreola MP; Orozco-Gutiérrez MH; Mariscal-Ramírez I; Pineda-Razo TD; Alcaraz-Wong AA; Marín-Contreras ME; Rosales-Reynoso MA
    J Egypt Natl Canc Inst; 2024 Apr; 36(1):10. PubMed ID: 38556604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent Coding Sequence Variation Explains Only A Small Fraction of the Genetic Architecture of Colorectal Cancer.
    Timofeeva MN; Kinnersley B; Farrington SM; Whiffin N; Palles C; Svinti V; Lloyd A; Gorman M; Ooi LY; Hosking F; Barclay E; Zgaga L; Dobbins S; Martin L; Theodoratou E; Broderick P; Tenesa A; Smillie C; Grimes G; Hayward C; Campbell A; Porteous D; Deary IJ; Harris SE; Northwood EL; Barrett JH; Smith G; Wolf R; Forman D; Morreau H; Ruano D; Tops C; Wijnen J; Schrumpf M; Boot A; Vasen HF; Hes FJ; van Wezel T; Franke A; Lieb W; Schafmayer C; Hampe J; Buch S; Propping P; Hemminki K; Försti A; Westers H; Hofstra R; Pinheiro M; Pinto C; Teixeira M; Ruiz-Ponte C; Fernández-Rozadilla C; Carracedo A; Castells A; Castellví-Bel S; Campbell H; Bishop DT; Tomlinson IP; Dunlop MG; Houlston RS
    Sci Rep; 2015 Nov; 5():16286. PubMed ID: 26553438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective comparison of family medical history with personal genome screening for risk assessment of common cancers.
    Heald B; Edelman E; Eng C
    Eur J Hum Genet; 2012 May; 20(5):547-51. PubMed ID: 22215421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of MLH1 and MSH2 genes and the risk of lung cancer among never smokers.
    Lo YL; Hsiao CF; Jou YS; Chang GC; Tsai YH; Su WC; Chen KY; Chen YM; Huang MS; Hsieh WS; Chen CJ; Hsiung CA
    Lung Cancer; 2011 Jun; 72(3):280-6. PubMed ID: 21093954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variants in primary cilia-related genes associated with the prognosis of first-line chemotherapy in colorectal cancer.
    Qiu L; Chen S; Ben S; Cui J; Lu S; Qu R; Lv J; Shao W; Yu Q
    Cancer Med; 2024 Jan; 13(2):e6996. PubMed ID: 38334481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do non-pathogenic variants of DNA mismatch repair genes modify neurofibroma load in neurofibromatosis type 1?
    Harder A
    Childs Nerv Syst; 2022 Apr; 38(4):705-713. PubMed ID: 34997843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micronuclei Formation upon Radioiodine Therapy for Well-Differentiated Thyroid Cancer: The Influence of DNA Repair Genes Variants.
    S Santos L; M Gil O; N Silva S; C Gomes B; C Ferreira T; Limbert E; Rueff J
    Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32957448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA Mismatch Repair Gene Variants in Sporadic Solid Cancers.
    Caja F; Vodickova L; Kral J; Vymetalkova V; Naccarati A; Vodicka P
    Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32756484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA repair in cancer initiation, progression, and therapy-a double-edged sword.
    Kiwerska K; Szyfter K
    J Appl Genet; 2019 Nov; 60(3-4):329-334. PubMed ID: 31468363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Polymorphisms of DNA Repair Pathways in Sporadic Colorectal Carcinogenesis.
    Liu J; Zheng B; Li Y; Yuan Y; Xing C
    J Cancer; 2019; 10(6):1417-1433. PubMed ID: 31031852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pooling-analysis on hMLH1 polymorphisms and cancer risk: evidence based on 31,484 cancer cases and 45,494 cancer-free controls.
    Li S; Zheng Y; Tian T; Wang M; Liu X; Liu K; Zhai Y; Dai C; Deng Y; Li S; Dai Z; Lu J
    Oncotarget; 2017 Nov; 8(54):93063-93078. PubMed ID: 29190978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism of MSH2 Gly322Asp and MLH1 -93G>A in non-familial colon cancer - a case-controlled study.
    Mik M; Dziki L; Malinowska K; Trzcinski R; Majsterek I; Dziki A
    Arch Med Sci; 2017 Oct; 13(6):1295-1302. PubMed ID: 29181059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A modifier of Huntington's disease onset at the MLH1 locus.
    Lee JM; Chao MJ; Harold D; Abu Elneel K; Gillis T; Holmans P; Jones L; Orth M; Myers RH; Kwak S; Wheeler VC; MacDonald ME; Gusella JF
    Hum Mol Genet; 2017 Oct; 26(19):3859-3867. PubMed ID: 28934397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intronic and promoter polymorphisms of hMLH1/hMSH2 and colorectal cancer risk in Heilongjiang Province of China.
    Li G; Hu F; Yuan F; Fan J; Yu Z; Wu Z; Zhao X; Li Y; Li S; Rong J; Cui B; Dong X; Yuan H; Zhao Y
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1393-404. PubMed ID: 25560462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of polymorphisms in hMLH1/hMSH2 for colorectal cancer.
    Wang Y; Li G; Hu F; Bi H; Wu Z; Zhao X; Li Y; Li S; Li D; Cui B; Dong X; Zhao Y
    Med Oncol; 2014 Jun; 31(6):975. PubMed ID: 24793746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.